Evidence map›Paper›PMID 26696967›Full record

ArticleFrontiers in microbiology2015

Candida albicans Shaving to Profile Human Serum Proteins on Hyphal Surface.

Elvira Marín, Claudia M Parra-Giraldo, Carolina Hernández-Haro, María L Hernáez, César Nombela, Lucía Monteoliva, Concha Gil

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Glyceraldehyde 3-Phosphate Dehydrogenase on the Surface ofInternational journal of molecular sciences · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. The Complement Binding and Inhibitory Protein CbiA ofFrontiers in cellular and infection microbiology · 2018
    Article
  17. UnravelingFrontiers in microbiology · 2018
    Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Elvira MarínDepartamento de Microbiología II, Facultad de Farmacia, Universidad Complutense de Madrid Madrid, Spain.
Claudia M Parra-GiraldoDepartamento de Microbiología II, Facultad de Farmacia, Universidad Complutense de Madrid Madrid, Spain.
Carolina Hernández-HaroDepartamento de Microbiología II, Facultad de Farmacia, Universidad Complutense de Madrid Madrid, Spain.
María L HernáezUnidad de Proteómica, Facultad de Farmacia, Universidad Complutense de Madrid Madrid, Spain.
César NombelaDepartamento de Microbiología II, Facultad de Farmacia, Universidad Complutense de Madrid Madrid, Spain ; Instituto Ramón y Cajal de Investigación Sanitaria Madrid, Spain.
Lucía MonteolivaDepartamento de Microbiología II, Facultad de Farmacia, Universidad Complutense de Madrid Madrid, Spain ; Instituto Ramón y Cajal de Investigación Sanitaria Madrid, Spain.
Concha GilDepartamento de Microbiología II, Facultad de Farmacia, Universidad Complutense de Madrid Madrid, Spain ; Unidad de Proteómica, Facultad de Farmacia, Universidad Complutense de Madrid Madrid, Spain ; Instituto Ramón y Cajal de Investigación Sanitaria Madrid, Spain.
Universidad Complutense de Madrid · ESInstituto Ramón y Cajal de Investigación Sanitaria · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Candida albicans is a human opportunistic fungus and it is responsible for a wide variety of infections, either superficial or systemic. C. albicans is a polymorphic fungus and its ability to switch between yeast and hyphae is essential for its virulence. Once C. albicans obtains access to the human body, the host serum constitutes a complex environment of interaction with C. albicans cell surface in bloodstream. To draw a comprehensive picture of this relevant step in host-pathogen interaction during invasive candidiasis, we have optimized a gel-free shaving proteomic strategy to identify both, human serum proteins coating C. albicans cells and fungi surface proteins simultaneously. This approach was carried out with normal serum (NS) and heat inactivated serum (HIS). We identified 214 human and 372 C. albicans unique proteins. Proteins identified in C. albicans included 147 which were described as located at the cell surface and 52 that were described as immunogenic. Interestingly, among these C. albicans proteins, we identified 23 GPI-anchored proteins, Gpd2 and Pra1, which are involved in complement system evasion and 7 other proteins that are able to attach plasminogen to C. albicans surface (Adh1, Eno1, Fba1, Pgk1, Tdh3, Tef1, and Tsa1). Furthermore, 12 proteins identified at the C. albicans hyphae surface induced with 10% human serum were not detected in other hypha-induced conditions. The most abundant human proteins identified are involved in complement and coagulation pathways. Remarkably, with this strategy, all main proteins belonging to complement cascades were identified on the C. albicans surface. Moreover, we identified immunoglobulins, cytoskeletal proteins, metabolic proteins such as apolipoproteins and others. Additionally, we identified more inhibitors of complement and coagulation pathways, some of them serpin proteins (serine protease inhibitors), in HIS vs. NS. On the other hand, we detected a higher amount of C3 at the C. albicans surface in NS than in HIS, as validated by immunofluorescence.

Indexed as

Candida albicanscoagulation pathwayscomplement pathwaysGPI-anchored proteinshost-pathogen interactionhuman serumshavingsurface proteins

Identifiers

PMID26696967
PMCPMC4672057
OpenAlexW2238481953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.